Antiparkinsonian potential of the group II mGluR agonist, DCG-IV, following intraventricular administration in the reserpine-treated rat model of Parkinson's disease

L Dawson; M Megalou; S Duty

Antiparkinsonian potential of the group II mGluR agonist, DCG-IV, following intraventricular administration in the reserpine-treated rat model of Parkinson's disease

L Dawson, M Megalou, S Duty

Wolfson SPaRC

Research output: Contribution to journal › Meeting abstract

Original language	English
Pages (from-to)	U35 - U35
Journal	British Journal of Pharmacology
Volume	128
Publication status	Published - 1999

Cite this

@article{441723201c674013ae70d2a3319d0c31,

title = "Antiparkinsonian potential of the group II mGluR agonist, DCG-IV, following intraventricular administration in the reserpine-treated rat model of Parkinson's disease",

author = "L Dawson and M Megalou and S Duty",

year = "1999",

language = "English",

volume = "128",

pages = "U35 -- U35",

journal = "British Journal of Pharmacology",

issn = "1476-5381",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Antiparkinsonian potential of the group II mGluR agonist, DCG-IV, following intraventricular administration in the reserpine-treated rat model of Parkinson's disease

AU - Dawson, L

AU - Megalou, M

AU - Duty, S

PY - 1999

Y1 - 1999

M3 - Meeting abstract

SN - 1476-5381

VL - 128

SP - U35 - U35

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

ER -